Search

everythinglearnresearchcommunity

for

Search:↓

High kallistatin levels in diabetics worsen wound healing by blocking important cell signals.

The lotion CG428 did not show effectiveness in treating permanent hair loss in breast cancer survivors.

Bicalutamide may effectively treat female pattern hair loss with minimal side effects.

Letrozole reduces seizures but not brain damage in mice.

Upadacitinib effectively treats skin conditions like eczema and psoriasis and is becoming more widely used and affordable.

Oral baricitinib is effective and safe for treating alopecia areata.

Baricitinib effectively reduces hair loss in severe alopecia areata with mild side effects.

A man developed a rash similar to pityriasis rubra pilaris after starting sorafenib for cancer, possibly due to the drug's effect on skin cells.

Baricitinib effectively treats severe alopecia for up to 104 weeks.

ATR12-351 ointment safely delivers LEKTI protein to the skin, reducing enzyme activity in Netherton syndrome.

Anti-PD-L1 immunotherapy can cause hair loss and unexpected hair color change, but treatment can restore hair growth and color.

Dermatologists are crucial for managing skin side effects in metastatic melanoma patients using vemurafenib and ipilimumab.

Alpha-difluoromethylornithine prevents cancer in mice but causes hair loss.

Tofacitinib helped a woman with total-body hair loss grow her hair back.

A specific drug can help treat Lichen Planopilaris, a condition causing permanent hair loss.

JAK inhibitors show promise for treating alopecia areata, but more research is needed.

Tofacitinib and adalimumab are promising treatments for cicatricial alopecia with few side effects.

Targeting androgen receptor signaling may improve acute myeloid leukemia treatment.

Janus kinase inhibitors are promising for treating scarring alopecia, but more research is needed for safety and personalized treatments.

Analog 23 is a promising compound for prostate cancer treatment.

Most patients experienced significant but reversible hair loss during treatment.

JAK inhibitors help hair growth by boosting beta-catenin activity in hair root cells.

Aumolertinib is effective and well-tolerated for treating advanced lung cancer with EGFR mutations.

A new drug, abrocitinib, helped a child with severe hair loss regrow hair.

Ritlecitinib may cause severe musculoskeletal pain in some alopecia universalis patients.